Constellate Proteomics had an enlightening blast at LSX World Congress in London! For three days straight, Dennis de Beeld and Carlos de Lannoy shared our innovation with investors.
We will be raising seed funding soon. The goal: to shorten antibody development timelines by 50% with our smarter analytical solutions for antibody titer and glycosylation.
Did we miss you? Are you investing in deeptech bioanalytical solutions? Reach out, we're always ready to talk!
Thanks to LSX - partnering for Life Science eXecutives for making it happen!